loadpatents
name:-0.011662006378174
name:-0.018504858016968
name:-0.0042769908905029
Stoit; Axel Patent Filings

Stoit; Axel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stoit; Axel.The latest application filed is for "spiro-cyclic amine derivatives as s1p modulators".

Company Profile
4.19.22
  • Stoit; Axel - Hoofddorp NL
  • Stoit; Axel - Weesp NL
  • Stoit; Axel - CP Weesp NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Spiro-cyclic amine derivatives as S1P modulators
Grant 11,427,598 - Stoit , et al. August 30, 2
2022-08-30
Spiro-cyclic Amine Derivatives As S1p Modulators
App 20210130364 - Stoit; Axel ;   et al.
2021-05-06
Spiro-cyclic amine derivatives as S1P modulators
Grant 10,807,991 - Stoit , et al. October 20, 2
2020-10-20
Spiro-cyclic Amine Derivatives As S1p Modulators
App 20190218227 - Stoit; Axel ;   et al.
2019-07-18
Spiro-cyclic amine derivatives as S1P modulators
Grant 10,179,791 - Stoit , et al. Ja
2019-01-15
Spiro-cyclic amine derivatives as S1P modulators
Grant 9,951,084 - Stoit , et al. April 24, 2
2018-04-24
Spiro-cyclic Amine Derivatives As S1p Modulators
App 20160340363 - Stoit; Axel ;   et al.
2016-11-24
(Thio)morpholine derivatives as S1P modulators
Grant 9,273,017 - Iwema Bakker , et al. March 1, 2
2016-03-01
(thio)morpholine Derivatives As S1p Modulators
App 20150239857 - Iwema Bakker; Wouter I. ;   et al.
2015-08-27
(Thio)morpholine derivatives as S1P modulators
Grant 9,045,441 - Iwema Bakker , et al. June 2, 2
2015-06-02
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT.sub.6 antagonists
Grant 8,901,108 - Van Loevezijn , et al. December 2, 2
2014-12-02
Heterocyclic compounds with affinity to muscarinic receptors
Grant 8,735,388 - Stoit , et al. May 27, 2
2014-05-27
Heterocyclic Compounds Iwth Affinity To Muscarinic Receptors
App 20140080861 - Stoit; Axel ;   et al.
2014-03-20
Arylsulfonyl Pyrazoline Carboxamidine Derivatives As 5-ht6 Antagonists
App 20140011775 - van Loevezijn; Arnold ;   et al.
2014-01-09
Heterocyclic compounds with affinity to muscarinic receptors
Grant 8,586,606 - Stoit , et al. November 19, 2
2013-11-19
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT.sub.6 antagonists
Grant 8,563,723 - Van Loevezijn , et al. October 22, 2
2013-10-22
Spiro-cyclic Amine Derivatives As S1p Modulators
App 20130196998 - Stoit; Axel ;   et al.
2013-08-01
(thio)morpholine Derivatives As S1p Modulators
App 20120220552 - Iwema Bakker; Wouter I. ;   et al.
2012-08-30
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
Grant 8,252,930 - Stoit , et al. August 28, 2
2012-08-28
Heterocyclic Compounds With Affinity To Muscarinic Receptors
App 20120095039 - Stoit; Axel ;   et al.
2012-04-19
Phenylpiperazine derivatives with a combination of partial dopamine-D.sub.2 receptor agonism and serotonin reuptake inhibition
Grant 8,101,619 - Feenstra , et al. January 24, 2
2012-01-24
Heterocyclic compounds with affinity to muscarinic receptors
Grant 8,084,473 - Stoit , et al. December 27, 2
2011-12-27
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
Grant 7,964,728 - Stoit , et al. June 21, 2
2011-06-21
Azaindole Derivatives With A Combination Of Partial Nicotinic Acetyl-choline Receptor Agonism And Dopamine Reuptake Inhibition
App 20110053962 - Stoit; Axel ;   et al.
2011-03-03
Arylsulfonyl Pyrazoline Carboxamidine Derivatives As 5-ht6 Antagonists
App 20110046171 - Loevezijn; Arnold Van ;   et al.
2011-02-24
N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
Grant 7,696,383 - Turski , et al. April 13, 2
2010-04-13
Heterocyclic Compounds with Affinity to Muscarinic Receptors
App 20090018160 - Stoit; Axel ;   et al.
2009-01-15
N-oxides Of Venlafaxine And O-desmethylvenlafaxine As Prodrugs
App 20090005455 - Turski; Lechoslaw A. ;   et al.
2009-01-01
Sildenafil N-oxide As Prodrug
App 20090005395 - Turski; Lechoslaw A. ;   et al.
2009-01-01
Azaindole Derivatives With A Combination Of Partial Nicotinic Acetyl-choline Receptor Agonism And Dopamine Reuptake Inhibition
App 20080009514 - STOIT; Axel ;   et al.
2008-01-10
Phenypiperazine Derivatives With A Combination Of Partial Dopamine-d2 Receptor Agonism And Serotonin Reuptake Inhibition
App 20070142397 - Feenstra; Roelof W. ;   et al.
2007-06-21
Phenylpiperazine Derivatives With A Combination Of Partial Dopamine-d2 Receptor Agonism And Serotonin Reuptake Inhibition
App 20070072870 - Feenstra; Roelof ;   et al.
2007-03-29
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060247256 - Feenstra; Roelof W. ;   et al.
2006-11-02
Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060122247 - Feenstra; Roelof W. ;   et al.
2006-06-08
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060122190 - Feenstra; Roelof W. ;   et al.
2006-06-08
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060122189 - Feenstra; Roelof W. ;   et al.
2006-06-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed